Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivo
International Immunopharmacology · 2026-07 · 180 · 116672
DOI: 10.1016/j.intimp.2026.116672 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Zhirou Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases and College of Pharmaceutical Sciences, The Affiliated Guangji…. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Microglia, Neuroprotective Agents, Neuroinflammatory Diseases. Die Arbeit nennt 70 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China.
Abstract (Originalsprache)
Microglia-mediated neuroinflammation is a central contributor to the pathogenesis and progression of neurological disorders, including intracerebral hemorrhage (ICH). Vitamin K comprises a family of structurally analogous vitamins crucial for blood clotting and bone integrity. Although vitamin K has demonstrated anti-inflammatory properties in vitro, its potential for mitigating neuroinflammation and providing neuroprotection, particularly within the context of intracerebral hemorrhage, remains to be elucidated. Here, we demonstrate that the synthetic vitamin K derivative vitamin K3 (VK3) exerts potent anti-inflammatory and neuroprotective effects in vitro and in vivo. In cultured microglia, VK3 and VK4 markedly suppressed lipopolysaccharide (LPS)-induced expression of pro-inflammatory mediators, whereas vitamins K1 and K2 showed minimal efficacy or greater cytotoxicity. Mechanistically, VK3 inhibited NF-κB signaling by reducing phosphorylation and nuclear translocation of the p65 subunit, thereby limiting downstream transcriptional activation of inflammatory genes. VK3 also attenuated thrombin-induced microglial activation, a key pathological trigger in ICH. The neuroprotective efficacy of VK3 was further validated in mouse models of acute and long-term ICH. Post-injury administration of VK3 significantly reduced microglial activation and neuroinflammatory responses, preserved neuronal integrity, and improved both motor and neurological performance. Notably, VK3 treatment conferred sustained functional benefits and ameliorated long-term neurological deficits following ICH. Collectively, these findings identify VK3 as a potent modulator of microglia-driven neuroinflammation and highlight short-chain vitamin K derivatives as promising therapeutic candidates for ICH and other neuroinflammatory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases and College of Pharmaceutical Sciences, The Affiliated Guangji Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 2…
- Haian Hospital of Traditional Chinese Medicine, Haian, Jiangsu 226600, China. Electronic address: LHSS666@163.com.
- Haian Hospital of Traditional Chinese Medicine, Haian, Jiangsu 226600, China. Electronic address: yujianzhong1981@163.com.
Förderung
- National Key Research and Development Program of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Natural Science Foundation of China
Zitieren
APA
Xu, Z., Chen, K., Ouyang, J., Pei, P., Yang, L., Zhan, S., Zhong, L., Sun, R., Sun, X., Du, X., Zhen, X., Zheng, L. T., Liu, H., & Yu, J. (2026). Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivo. International Immunopharmacology, 180, 116672. https://doi.org/10.1016/j.intimp.2026.116672
Vancouver
Xu Z, Chen K, Ouyang J, Pei P, Yang L, Zhan S, et al. Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivo. International Immunopharmacology. 2026;180:116672. doi:10.1016/j.intimp.2026.116672
BibTeX
@article{Xu2026,
author = {Xu, Zhirou and Chen, Kexin and Ouyang, Jiawei and Pei, Panpan and Yang, Lin and Zhan, Siqin and Zhong, Lili and Sun, Renjuan and Sun, Xiaohui and Du, Xiangdong and Zhen, Xuechu and Zheng, Long-Tai and Liu, Hua and Yu, Jianzhong},
title = {Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivo},
journal = {International Immunopharmacology},
year = {2026},
volume = {180},
pages = {116672},
doi = {10.1016/j.intimp.2026.116672}
}
EUVIMED